Giuseppe PERCOCO

Dr. Giuseppe PERCOCO

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2020 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
GPGiuseppe PERCOCO
Giuseppe PERCOCO
APAngela Patatian
Angela Patatian
FEFlorine Eudier
Florine Eudier
MGMichel Grisel
Michel Grisel
TBThomas Bader
Thomas Bader
PBPhilippe Benech
Philippe Benech

12 November 2024 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
L-Laurent Peno -Mazzarino
Laurent Peno -Mazzarino
OJOlivier Jeanneton
Olivier Jeanneton
SSStéphanie Almeida Scalvino
Stéphanie Almeida Scalvino
GPGiuseppe PERCOCO
Giuseppe PERCOCO
GBGallic Beauchef
Gallic Beauchef
KPKarl Pays
Karl Pays

Verified
Journal Article
Open access
PDF file
SMStefano Ministrini
Stefano Ministrini
LLLuca Liberale
Luca Liberale
HEHanns Erle
Hanns Erle
GPGiuseppe PERCOCO
Giuseppe PERCOCO
ATAli TFAYLI
Ali TFAYLI
GCGiovanni Camici
Giovanni Camici
Nicotinamide adenine-dinucleotide (NAD+) supplementation is a promising strategy to delay cellular aging in different areas, including cosmetic dermatology. However, low bioavailability and stability of NAD+ formulations are the main factors limiting its effectiveness as an anti-aging treatment. In light of the above, a liposomal formulation of NAD+ (LF-NAD+) was tested in this study and compared to NAD+ alone in primary human aortic endothelial cells (HAECs) and primary human epidermal keratinocytes (HEKas). Intracellular NAD+ was measured using a colorimetric assay. Cell survival was derived from lactate dehydrogenase release in supernatants. Cell senescence was measured by senescence-associated β-galactosidase staining. Molecular mechanisms underlying the reported effects were analyzed by Western blot. Skin penetration of NAD+ was measured ex vivo in skin explants, using infrared spectroscopy. Compared to control NAD+ alone, the LF-NAD+ formulation increased the intracellular NAD+ content and cell survival in HAECs, but not in HEKas. Instead, a significant reduction in the number of senescent cells was observed in both HAECs and HEKas. LF-NAD+ treatment was associated with a reduced expression of p16 in both HAECs and HEKas, and to a significant reduction in p21 in HEKas alone. Finally, LF-NAD+ increases the skin penetration of the active substance NAD+ by 30% compared to the application of NAD+ alone. LF-NAD+, enhances the anti-aging effects of NAD+ on vascular and skin cells. Such in vitro findings might indicate a potential anti-aging role in the microcirculation and in the epidermidis.

23 January 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
FAFabrice Avaltroni
Fabrice Avaltroni
CBCarolina Burki
Carolina Burki
FWFranziska Weichmann
Franziska Weichmann
GPGiuseppe PERCOCO
Giuseppe PERCOCO
L-Laurent Peno -Mazzarino
Laurent Peno -Mazzarino
ELElian Lati
Elian Lati
Oxidative stress is a major factor in skin aging and various skin pathologies. Environmental pollutants exacerbate this stress by generating reactive oxygen species (ROS), disrupting the skin’s redox balance. Pycnogenol®, a French maritime pine bark, extract is standardized to contain 70 ± 5% procyanidins and known to mitigate oxidative damage and inflammation. This study aims to evaluate the potential antipollution and antioxidant effects of Pycnogenol® on skin. Ex vivo human skin explants were treated with varying concentrations of Pycnogenol® (0.5%, 1%, and 2%) and then exposed to a mixture of pollutants. The expression of stress markers Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) and AHR (Aryl Hydrocarbon Receptor) were evaluated using immunostaining. Lipid peroxidation levels were measured by quantifying malondialdehyde (MDA) concentrations. The extract significantly decreased Nrf2 expression by 40% (p = 0.003) and 23% (p = 0.048) with a dose of 2% and 1%, respectively. After pollutant exposure, Pycnogenol® (0.5%, 1%, and 2%) reduced Nrf2 over-expression in a dose–response manner by 29% (p = 0.03), 58% (p = 0.004) and 64% (p = 0.002) respectively. Pycnogenol® at 0.5%, 1%, and 2% significantly reduced AHR over-expression by 61% (p < 0.0001), 76% (p < 0.0001) and 85% (p < 0.0001), respectively. Pycnogenol® (1%, and 2%) decreased MDA levels following pollutant exposure by 17% (p = 0.06) and 25% (p = 0.01) respectively. In a dose-dependent manner, Pycnogenol® exhibited a strong protective effect against pollution, significantly reducing pollutant-induced basal oxidative stress (MDA) and over-expression of Nrf2 and AHR, key factors in oxidative stress and detoxification. Pycnogenol® also increased AHR expression in the absence of pollutants, which may reflect an adaptive cellular response.